Author: Stan N. Finkelstein
Stan N. Finkelstein, M.D. is a Senior Research Scientist at the MIT and Co-Director of the Program on the Pharmaceutical Industry (POPI). He also serves as a Senior Lecturer in the Department of Health Care Policy at Harvard Medical School and a member of the faculty of the Harvard-MIT Division of Health Sciences & Technology (HST) and the MIT Engineering Systems Division (ESD). He received his Masters of Science and Bachelors of Science degrees in Chemical Engineering from MIT in 1971, and an M.D. from Harvard Medical School in 1975.
Since 1975, he has worked actively in the field of medical technology assessment and transfer at MIT. He conducts research and teaches classes in the development and evaluation of medical practice and technology and in health economics and policy, both at MIT and Harvard Medical School.
An active consultant to U.S. and international pharmaceutical, biotechnology, and medical device firms, as well as to health services organizations and government agencies; Dr. Finkelstein is an expert in outcomes research. His areas of specialization extend to the business-government interface related to medical technology, especially product development, clinical research design and third-party reimbursement. Dr. Finkelstein is author, editor, or contributor to several books and numerous articles on these subjects and other issues in health economics.
Dr. Finkelstein's current research interests include analyses relating to the economics of illness and pharmaceutical treatment. His publications include studies of cost of illness and cost-effectiveness of treatment. He is co-author of several recent articles that address the link between treatment of illness and productivity at work, and the role of advancing science and technology in changing patterns of medical treatment.